Voloridge Investment Management’s Wave Life Sciences WVE Stock Holding History

Voloridge Investment Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.09M	Sell	288,502 -433,735	-60%	-$5.65M	0.01%	823
2025 Q4	$12.3M	Buy	+722,237	New	+$7.34M	0.04%	521
2025 Q3	–	Sell	-683,193	Closed	-$4.44M	–	1424
2025 Q2	$4.44M	Sell	683,193 -87,514	-11%	-$578K	0.02%	782
2025 Q1	$6.23M	Sell	770,707 -75,123	-9%	-$822K	0.02%	723
2024 Q4	$10.5M	Buy	+845,830	New	+$11.3M	0.04%	560
2021 Q2	–	Sell	-14,053	Closed	-$79K	–	1813
2021 Q1	$79K	Sell	14,053 -125,038	-90%	-$1.2M	﹤0.01%	1346
2020 Q4	$1.09M	Sell	139,091 -252,098	-64%	-$2.12M	0.01%	943
2020 Q3	$3.32M	Buy	391,189 +353,128	+928%	+$3.87M	0.03%	559
2020 Q2	$396K	Sell	38,061 -9,949	-21%	-$93.6K	﹤0.01%	1078
2020 Q1	$450K	Buy	+48,010	New	+$409K	0.01%	741
2019 Q4	–	Sell	-12,899	Closed	-$265K	–	1375
2019 Q3	$265K	Sell	12,899 -9,517	-42%	-$218K	﹤0.01%	953
2019 Q2	$585K	Buy	+22,416	New	+$629K	0.02%	540

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

GSK plc London $599M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Voloridge Investment Management's WVE Position: Q1 2026 in Review

Voloridge Investment Management reduced its Wave Life Sciences (WVE) stake by 60% in Q1 2026, selling an estimated $5.65M and leaving 288,502 shares worth $2.09M. The position accounts for 0.01% of the portfolio, ranked #823.

Voloridge Investment Management first reported a position in WVE in Q2 2019 and has held it in 12 quarters since. The position peaked at $12.3M in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

Voloridge Investment Management held 288,502 shares of Wave Life Sciences worth $2.09M as of Q1 2026.
Voloridge Investment Management sold 433,735 Wave Life Sciences shares in Q1 2026, an estimated $5.65M.
Wave Life Sciences made up 0.01% of Voloridge Investment Management's portfolio in Q1 2026, its #823 holding.
Voloridge Investment Management first reported a position in Wave Life Sciences in Q2 2019 and has held it in 12 quarters since.
Voloridge Investment Management's Wave Life Sciences position peaked at $12.3M in Q4 2025.
230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.